Brief: FDA Permits Marketing Of Cue Health's Covid-19 At-Home Test
06/06/2023 20:10
June 6 (Reuters) - FDA :
* FDA PERMITS MARKETING OF CUE HEALTH'S COVID-19 AT-HOME
TEST
USING TRADITIONAL PREMARKET REVIEW PROCESS
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022